BioXcel Therapeutics (BTAI) PT Lowered to $25 at Guggenheim
Tweet
Share
E-mailGet Alerts BTAI Hot Sheet
Price: $1.13 +6.60%
Rating Summary:
7 Buy, 6 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Rating Summary:
7 Buy, 6 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Join SI Premium – FREE
Guggenheim analyst Yatin Suneja lowered the price target on BioXcel Therapeutics (NASDAQ: BTAI) to $25.00 (from $28.00) while maintaining a Buy rating.
You May Also Be Interested In
- Golar LNG Ltd. (GLNG) PT Raised to $70 at BTIG
- Legence Corp (LGN) PT Lowered to $100 at BTIG
- Cellebrite (CLBT) PT Lowered to $15 at TD Cowen
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
